The prefilled syringes market is expected to reach US$ 56 billion by 2032.
The prefilled syringes market is expected grow at a CAGR of 22.93% between 2023 to 2032.
The prefilled syringes market size was estimated to be US$ 19 billion in 2022.
The prefilled syringes analysis market has been assessed for the years 2019 to 2032.
Improved convenience, affordability, sterility, safety, and accuracy delivered by prefilled syringes over traditional syringes are the key parameters fueling the widespread adoption of the prefilled syringes around the world. The global prefilled syringes market is anticipated to gain traction during the forecast period.
North America contributed the largest share to the global prefilled syringes market and is anticipated to be a dominating geography during the forecast period owing to increasing investment in development of novel drugs and advanced therapeutics, early adoption of prefilled syringes, high penetration across different end use sectors, and presence of leading pharmaceutical manufacturers.
Some of the key players in the global prefilled syringes market include Baxter International, Becton, Dickinson and Company, Abbott Laboratories, Gerresheimer AG, Vetter Pharma International GmbH, Nipro Corporation, Medtronic plc., Unilife Corporation, Terumo Medical Corporation, and West Pharmaceutical Services, Inc.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved